Edition:
United Kingdom

People: Anthem Inc (ANTM.N)

ANTM.N on New York Stock Exchange

265.07USD
17 May 2019
Change (% chg)

$1.25 (+0.47%)
Prev Close
$263.82
Open
$261.00
Day's High
$267.62
Day's Low
$261.00
Volume
230,326
Avg. Vol
387,249
52-wk High
$317.89
52-wk Low
$220.80

Boudreaux, Gail 

Ms. Gail K. Boudreaux is President, Chief Executive Officer, Director of the Company effective November 20, 2017. Prior to joining the Company, she served as Chief Executive Officer of GKB Global Health, LLC (health care strategy and business advisory firm) from July 2015 to November 2017. Prior thereto, Ms. Boudreaux was Executive Vice President of UnitedHealth Group Incorporated (diversified health care company) from May 2008 to February 2015, President of United HealthCare (managed health care company), a subsidiary of UnitedHealth Group Incorporated, from May 2008 to January 2011 and Chief Executive Officer of United HealthCare from January 2011 to November 2014. Before joining United HealthCare, she worked at Health Care Services Corporation (“HCSC”) (health insurance company) as Executive Vice President of External Operations from December 2005 to April 2008 and as President of Blue Cross Blue Shield of Illinois from 2002 to May 2005. Before joining HCSC, Ms. Boudreaux held various positions at Aetna Inc. (managed health care company), including Senior Vice President, Group Insurance. Ms. Boudreaux has served as a director of Zimmer Biomet Holdings, Inc. (medical device company) since 2012. She also serves as a director of the BCBSA, the National Institute for Health Care Management, Health Services Foundation, Dartmouth College Board of Trustees, and the Central Indiana Corporate Partnership, and as a member of the Business Roundtable. She previously served as a director of Xcel Energy, Inc. (utility holding company) from May 2012 to December 2017, Novavax, Inc. (biotechnology company) from June 2015 to November 2017 and Genzyme Corporation (biotechnology company) from 2004 to 2011.

Basic Compensation

Total Annual Compensation, USD 161,538
Restricted Stock Award, USD 2,000,220
Long-Term Incentive Plans, USD --
All Other, USD 4,500
Fiscal Year Total, USD 2,166,250

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --